Published October 25, 2017 | Version Published
Patent Open

Human immunodeficiency virus neutralizing antibodies and methods of use thereof [APPLICATION]

Abstract

The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.

Additional Information

US Application. Application number US14118496. Priority date 2011-05-17. Filing date 2012-05-17. Publication date 2014-11-06. Government Interests: The research leading to the present invention was supported in part, by National Institutes of Health Grant No. P01 AI08677-01. Accordingly, the U.S. Government has certain rights in this invention.

Attached Files

Published - US20140328862A1.pdf

Files

US20140328862A1.pdf

Files (8.3 MB)

Name Size Download all
md5:64c3b4636f8f31d92814264e61b157c2
8.3 MB Preview Download

Additional details

Identifiers

Eprint ID
82691
Resolver ID
CaltechAUTHORS:20171025-163159394

Funding

NIH
P01 AI08677-01

Dates

Created
2017-10-25
Created from EPrint's datestamp field
Updated
2019-10-03
Created from EPrint's last_modified field